The role of skin self-examination at the Swiss skin cancer day

BMC Health Services Research

Ryan Tandjung¹  Michel Wensing²  Brigitte Tag³  Antonio Cozzio⁴  Ralph Braun⁴  Thomas Rosemann¹  Muriel Meier¹  Nina Badertscher¹ 

[1] Institute for Primary Care, University of Zurich, University Hospital of Zurich, Pestalozzistrasse 24, Zürich, 8091, Switzerland;Radboud University Nijmegen Medical Centre, Post 114, Postbus 9101, Nijmegen, The Netherlands;Institute of Law, University of Zurich, Freiestrasse 15, Zürich, 8032, Switzerland;Department of Dermatology, University Hospital of Zurich, Rämistrasse 100, Zürich, 8091, Switzerland

关键词: Swiss skin cancer day;    Skin self-examination;    Prevention;    Skin cancer;   

Others  :  1091435
DOI  :  10.1186/s12913-014-0581-6

 received in 2013-06-19, accepted in 2014-11-04,  发布年份 2014

【 摘 要 】

Background

The rising incidence of melanoma – Switzerland has the highest incidence in Europe - is a major public health challenge. Swiss dermatologist introduced the “Swiss Skin Cancer Day” (SSCD) in 2006, which provides skin cancer screening at no costs. The aim of the study was to describe the participating subjects and their motivation and investigate factors influencing the probability of a clinical diagnosis of skin malignancy.

Methods

150 dermatologists were involved in the SSCD in May 2012. Dermatologists were not remunerated. Participants had the opportunity to show a single skin lesion to a dermatologist at no cost. A questionnaire for each participating subject collected data about subjects’ age, sex, risk factors and reason for encounter; furthermore the dermatologist noted down clinical diagnosis and further management. We used descriptive statistics to report characteristics of participants and skin lesions. We built two multiple logistic regression models, one regarding the clinical diagnosis of skin malignancy and one regarding the further management.

Results

5266 subjects (55.6% female) were assessed; in 308 (5.8%) participants a clinical diagnosis of skin malignancy was found. In 1732 participants (32.9%) a clinical follow up or an excision was recommended. In the multiple logistic regression model age, sex, skin phototype and the reason for participation at the SSCD were found as significant risk factors regarding the clinical diagnosis of skin malignancy. Participants with skin cancer risk factors were more likely to get a clinical follow up recommended even if the clinical diagnosis was benign.

Conclusion

A self-perceived suspicious lesion was the strongest predictor for a clinical diagnosis of skin malignancy at the SSCD. This suggests that skin self-examination might also work in general population. Future research should focus on better access to a specialist in case a suspicious skin lesion was discovered. Safety and quality of the SSCD should be further investigated, especially concerning the discrepancy between the low number of malignant lesions and the high quantity of participants where further clinical examinations or interventions were recommended.

【 授权许可】

   
2014 Badertscher et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]de Vries E, Coebergh JW: Cutaneous malignant melanoma in Europe. Eur J Cancer 2004, 40(16):2355-2366.
• [2]Epidemiology of Cancer: Melanoma accessed online June 10th 2013 via. 2013.
• [3]Ferlay J, Steliarova-Foucher E, Lortet-Tieulent J, Rosso S, Coebergh JWW, Comber H, Forman D, Bray F: Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur J Cancer 2013, 49(6):1374-1403.
• [4]Balch CM, Gershenwald JE, Soong SJ, Thompson JF, Atkins MB, Byrd DR, Buzaid AC, Cochran AJ, Coit DG, Ding S, Eggermont AM, Flaherty KT, Gimotty PA, Kirkwood JM, McMasters KM, Mihm MCJ, Morton DL, Ross MI, Sober AJ, Sondak VK: Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol 2009, 27(36):6199-6206.
• [5]Freedberg KA, Geller AC, Miller DR, Lew RA, Koh HK: Screening for malignant melanoma: A cost-effectiveness analysis. J Am Acad Dermatol 1999, 41(5 Pt 1):738-745.
• [6]Geller AC, Swetter SM, Oliveria S, Dusza S, Halpern AC: Reducing mortality in individuals at high risk for advanced melanoma through education and screening. J Am Acad Dermatol 2011, 65(5 Suppl 1):S87-S94.
• [7]Choudhury K, Volkmer B, Greinert R, Christophers E, Breitbart EW: Effectiveness of skin cancer screening programmes. Br J Dermatol 2012, 167(Suppl 2):94-98.
• [8]Geller AC, Greinert R, Sinclair C, Weinstock MA, Aitken J, Boniol M, Capellaro M, Dore JF, Elwood M, Fletcher SW, Gallagher R, Gandini S, Halpern AC, Katalinic A, Lucas R, Marghoob AA, Nolte S, Schuz J, Tucker MA, Volkmer B, Breitbart E: A nationwide population-based skin cancer screening in Germany: proceedings of the first meeting of the International Task Force on Skin Cancer Screening and Prevention (September 24 and 25, 2009). Cancer Epidemiol 2010, 34(3):355-358.
• [9]Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT: Screening for skin cancer. Am J Prev Med 2001, 20(3 Suppl):47-58.
• [10]Katalinic A, Waldmann A, Weinstock MA, Geller AC, Eisemann N, Greinert R, Volkmer B, Breitbart E: Does skin cancer screening save lives?: An observational study comparing trends in melanoma mortality in regions with and without screening. Cancer 2012, 118(21):5395-5402.
• [11]Wolff T, Tai E, Miller T: Screening for skin cancer: an update of the evidence for the U.S. Preventive Services Task Force. Ann Intern Med 2009, 150(3):194-198.
• [12]De Giorgi V, Grazzini M, Rossari S, Gori A, Papi F, Scarfi F, Savarese I, Gandini S: Is Skin Self-Examination for Cutaneous Melanoma Detection Still Adequate? A Retrospective Study Dermatol 2012, 225(1):31-36.
• [13]Breitbart EW, Waldmann A, Nolte S, Capellaro M, Greinert R, Volkmer B, Katalinic A: Systematic skin cancer screening in Northern Germany. J Am Acad Dermatol 2012, 66(2):201-211.
• [14]Eisemann N, Waldmann A, Katalinic A: [Incidence of melanoma and changes in stage-specific incidence after implementation of skin cancer screening in Schleswig-Holstein]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 2014, 57(1):77-83.
• [15]Pollitt RA, Geller AC, Brooks DR, Johnson TM, Park ER, Swetter SM: Efficacy of skin self-examination practices for early melanoma detection. Cancer Epidemiol Biomarkers Prev 2009, 18(11):3018-3023.
• [16]Swetter SM, Pollitt RA, Johnson TM, Brooks DR, Geller AC: Behavioral determinants of successful early melanoma detection: role of self and physician skin examination. Cancer 2012, 118(15):3725-3734.
• [17]Titus LJ, Clough-Gorr K, Mackenzie TA, Perry A, Spencer SK, Weiss J, Abrahams-Gessel S, Ernstoff MS: Recent skin self-examination and doctor visits in relation to melanoma risk and tumour depth. Br J Dermatol 2013, 168(3):571-576.
• [18]Weinstock MA, Risica PM, Martin RA, Rakowski W, Dube C, Berwick M, Goldstein MG, Acharyya S, Lasater T: Melanoma early detection with thorough skin self-examination: the “Check It Out” randomized trial. Am J Prev Med 2007, 32(6):517-524.
• [19]Badertscher N, Senn O, Rossi PO, Wensing M, Rosemann T, Tandjung R: [Skin cancer in primary care: frequency, need to further education and subjective diagnostic certainty. A cross sectional survey among general practitioners in Canton of Zurich]. Praxis (Bern 1994) 2013, 102(22):1353-1359.
• [20]Heinzerling LM, Dummer R, Panizzon RG, Bloch PH, Barbezat R, Burg G, League SC: Prevention campaign against skin cancer. Dermatology 2002, 205(3):229-233.
• [21]Bulliard JL, Maspoli M, Panizzon RG, Hohl D, Gueissaz F, Levi F: Evaluation of the Euromelanoma skin cancer screening campaign: the Swiss experience. J Eur Acad Dermatol Venereol 2008, 22(3):365-366.
• [22]Bulliard JL, Panizzon RG, Levi F: [Epidemiology of epithelial skin cancers]. Rev Med Suisse 2009, 5(200):882. 884–888
• [23]Stratigos AJ, Forsea AM, van der Leest RJ, de Vries E, Nagore E, Bulliard JL, Trakatelli M, Paoli J, Peris K, Hercogova J, Bylaite M, Maselis T, Correia O, Del Marmol V: Euromelanoma: a dermatology-led European campaign against nonmelanoma skin cancer and cutaneous melanoma. Past, present and future. Br J Dermatol 2012, 167(Suppl 2):99-104.
• [24]Paoli J, Danielsson M, Wennberg AM: Results of the ‘Euromelanoma Day’ screening campaign in Sweden 2008. J Eur Acad Dermatol Venereol 2009, 23(11):1304-1310.
• [25]Seidenari S, Benati E, Ponti G, Borsari S, Ferrari C, Albertini G, Altomare G, Arcangeli F, Aste N, Bernengo MG, Bongiorno MR, Borroni G, Calvieri S, Chimenti S, Cusano F, Fracchiolla C, Gaddoni G, Girolomoni G, Guarneri B, Lanzoni A, Lombardi M, Lotti T, Mariotti A, Marsili F, Micali G, Parodi A, Peris K, Peserico A, Quaglino P, Santini M, et al.: Italian Euromelanoma Day Screening Campaign (2005–2007) and the planning of melanoma screening strategies. Eur J Cancer Prev 2012, 21(1):89-95.
• [26]van der Leest RJT, de Vries E, Bulliard JL, Paoli J, Peris K, Stratigos AJ, Trakatelli M, Maselis TJEML, Situm M, Pallouras AC, Hercogova J, Zafirovik Z, Reusch M, Olah J, Bylaite M, Dittmar HC, Scerri L, Correia O, Medenica L, Bartenjev I, Guillen C, Cozzio A, Bogomolets OV, del Marmol V: The Euromelanoma skin cancer prevention campaign in Europe: characteristics and results of 2009 and 2010. J Eur Acad Dermatol 2011, 25(12):1455-1465.
• [27]Free skin cancer screenings, accessed online November 28th 2012. 2012.
• [28]Hansen RP, Olesen F, Sorensen HT, Sokolowski I, Sondergaard J: Socioeconomic patient characteristics predict delay in cancer diagnosis: a Danish cohort study. BMC Health Serv Res 2008, 8:49. BioMed Central Full Text
• [29]Huber CA, Bandi-Ott E, Kaser L, Rosemann T, Senn O: [Medical check-ups on the <>. Benefit for population at risk or self-selection of healthy and health-conscious patients?]. Praxis (Bern 1994) 2009, 98(24):1421-1427.
• [30]Research with humans [Forschung mit Menschen] accessed online June 19th 2013. 2009.
• [31]Hansen RP, Vedsted P, Sokolowski I, Sondergaard J, Olesen F: Time intervals from first symptom to treatment of cancer: a cohort study of 2,212 newly diagnosed cancer patients. BMC Health Serv Res 2011, 11:284. BioMed Central Full Text